Skip to main content
Top
Published in: BMC Immunology 1/2009

Open Access 01-12-2009 | Research article

Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes

Authors: Carina Strell, Anne Sievers, Philipp Bastian, Kerstin Lang, Bernd Niggemann, Kurt S Zänker, Frank Entschladen

Published in: BMC Immunology | Issue 1/2009

Login to get access

Abstract

Background

Neurotransmitters are important regulators of the immune system, with very distinct and varying effects on different leukocyte subsets. So far little is known about the impact of signals mediated by neurotransmitters on the function of CD8+ T lymphocytes. Therefore, we investigated the influence of norepinephrine, dopamine and substance P on the key tasks of CD8+ T lymphocytes: activation, migration, extravasation and cytotoxicity.

Results

The activation of naïve CD8+ T lymphocytes by CD3/CD28 cross-linking was inhibited by norepinephrine and dopamine, which was caused by a downregulation of interleukin (IL)-2 expression via Erk1/2 and NF-κB inhibition. Furthermore, all of the investigated neurotransmitters increased the spontaneous migratory activity of naïve CD8+ T lymphocytes with dopamine being the strongest inducer. In contrast, activated CD8+ T lymphocytes showed a reduced migratory activity in the presence of norepinephrine and substance P. With regard to extravasation we found norepinephrine to induce adhesion of activated CD8+ T cells: norepinephrine increased the interleukin-8 release from endothelium, which in turn had effect on the activated CXCR1+ CD8+ T cells. At last, release of cytotoxic granules from activated cells in response to CD3 cross-linking was not influenced by any of the investigated neurotransmitters, as we have analyzed by measuring the β-hexosamidase release.

Conclusion

Neurotransmitters are specific modulators of CD8+ T lymphocytes not by inducing any new functions, but by fine-tuning their key tasks. The effect can be either stimulatory or suppressive depending on the activation status of the cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Felten DL: Direct innervation of lymphoid organs: substrate for neurotransmitter signaling of cells of the immune system. Neuropsychobiol. 1993, 28: 110-2. 10.1159/000119011.CrossRef Felten DL: Direct innervation of lymphoid organs: substrate for neurotransmitter signaling of cells of the immune system. Neuropsychobiol. 1993, 28: 110-2. 10.1159/000119011.CrossRef
2.
go back to reference Fink T, Weihe E: Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation?. Neurosci Lett. 1988, 90: 39-44. 10.1016/0304-3940(88)90783-5.CrossRefPubMed Fink T, Weihe E: Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation?. Neurosci Lett. 1988, 90: 39-44. 10.1016/0304-3940(88)90783-5.CrossRefPubMed
3.
go back to reference Lang K, Bastian P: Neurotransmitter effects on tumor cells and leukocytes. Prog Exp Tumor Res. 2007, 39: 99-121. full_text.CrossRefPubMed Lang K, Bastian P: Neurotransmitter effects on tumor cells and leukocytes. Prog Exp Tumor Res. 2007, 39: 99-121. full_text.CrossRefPubMed
4.
5.
go back to reference Kin NW, Sanders VM: It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006, 79: 1093-104. 10.1189/jlb.1105625.CrossRefPubMed Kin NW, Sanders VM: It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006, 79: 1093-104. 10.1189/jlb.1105625.CrossRefPubMed
6.
go back to reference Lucin KM, Sanders VM, Jones TB, Malarkey WB, Popovich PG: Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol. 2007, 207: 75-84. 10.1016/j.expneurol.2007.05.019.PubMedCentralCrossRefPubMed Lucin KM, Sanders VM, Jones TB, Malarkey WB, Popovich PG: Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol. 2007, 207: 75-84. 10.1016/j.expneurol.2007.05.019.PubMedCentralCrossRefPubMed
7.
go back to reference Kohm AP, Sanders VM: Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001, 53: 487-525.PubMed Kohm AP, Sanders VM: Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001, 53: 487-525.PubMed
8.
go back to reference Grebe KM, Hickman HD, Irvine KR, Takeda K, Bennink JR, Yewdell JW: Sympathetic nervous system control of anti-influenza CD8+ T cell responses. Proc Natl Acad Sci USA. 2009, 106: 5300-5. 10.1073/pnas.0808851106.PubMedCentralCrossRefPubMed Grebe KM, Hickman HD, Irvine KR, Takeda K, Bennink JR, Yewdell JW: Sympathetic nervous system control of anti-influenza CD8+ T cell responses. Proc Natl Acad Sci USA. 2009, 106: 5300-5. 10.1073/pnas.0808851106.PubMedCentralCrossRefPubMed
9.
go back to reference Weihe E, Nohr D, Michel S, Muller S, Zentel HJ, Fink T, Krekel J: Molecular anatomy of the neuro-immune connection. Int J Neurosci. 1991, 59: 1-23. 10.3109/00207459108985446.CrossRefPubMed Weihe E, Nohr D, Michel S, Muller S, Zentel HJ, Fink T, Krekel J: Molecular anatomy of the neuro-immune connection. Int J Neurosci. 1991, 59: 1-23. 10.3109/00207459108985446.CrossRefPubMed
10.
go back to reference Barili P, Bronzetti E, Felici L, Ferrante F, Ricci A, Zaccheo D, Amenta F: Age-dependent changes in the expression of dopamine receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol. 1996, 71: 45-50. 10.1016/S0165-5728(96)00127-0.CrossRefPubMed Barili P, Bronzetti E, Felici L, Ferrante F, Ricci A, Zaccheo D, Amenta F: Age-dependent changes in the expression of dopamine receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol. 1996, 71: 45-50. 10.1016/S0165-5728(96)00127-0.CrossRefPubMed
11.
go back to reference Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L: Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol. 2001, 31: 3504-12. 10.1002/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F.CrossRefPubMed Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L: Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol. 2001, 31: 3504-12. 10.1002/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F.CrossRefPubMed
12.
go back to reference Watanabe Y, Nakayama T, Nagakubo D, Hieshima K, Jin Z, Katou F, Hashimoto K, Yoshie O: Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol. 2006, 176: 848-56.CrossRefPubMed Watanabe Y, Nakayama T, Nagakubo D, Hieshima K, Jin Z, Katou F, Hashimoto K, Yoshie O: Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol. 2006, 176: 848-56.CrossRefPubMed
13.
go back to reference Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, Matsushita S: Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun. 2008, 373: 286-91. 10.1016/j.bbrc.2008.06.012.CrossRefPubMed Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, Matsushita S: Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun. 2008, 373: 286-91. 10.1016/j.bbrc.2008.06.012.CrossRefPubMed
14.
go back to reference Hasko G, Szabo C, Nemeth ZH, Deitch EA: Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol. 2002, 122: 34-9. 10.1016/S0165-5728(01)00459-3.CrossRefPubMed Hasko G, Szabo C, Nemeth ZH, Deitch EA: Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol. 2002, 122: 34-9. 10.1016/S0165-5728(01)00459-3.CrossRefPubMed
15.
go back to reference Saha B, Mondal AC, Majumder J, Basu S, Dasgupta PS: Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism. Neuroimmunomodulation. 2001, 9: 23-33. 10.1159/000049004.CrossRefPubMed Saha B, Mondal AC, Majumder J, Basu S, Dasgupta PS: Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism. Neuroimmunomodulation. 2001, 9: 23-33. 10.1159/000049004.CrossRefPubMed
16.
go back to reference Torres KC, Antonelli LR, Souza AL, Teixeira MM, Dutra WO, Gollob KJ: Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. J Neuroimmunol. 2005, 166: 144-57. 10.1016/j.jneuroim.2005.06.006.CrossRefPubMed Torres KC, Antonelli LR, Souza AL, Teixeira MM, Dutra WO, Gollob KJ: Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. J Neuroimmunol. 2005, 166: 144-57. 10.1016/j.jneuroim.2005.06.006.CrossRefPubMed
17.
go back to reference Ghosh MC, Mondal AC, Basu S, Banerjee S, Majumder J, Bhattacharya D, Dasgupta PS: Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. Int Immunopharmacol. 2003, 3: 1019-26. 10.1016/S1567-5769(03)00100-0.CrossRefPubMed Ghosh MC, Mondal AC, Basu S, Banerjee S, Majumder J, Bhattacharya D, Dasgupta PS: Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. Int Immunopharmacol. 2003, 3: 1019-26. 10.1016/S1567-5769(03)00100-0.CrossRefPubMed
18.
go back to reference Herpfer I, Lieb K: Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs. 2005, 19: 275-93. 10.2165/00023210-200519040-00001.CrossRefPubMed Herpfer I, Lieb K: Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs. 2005, 19: 275-93. 10.2165/00023210-200519040-00001.CrossRefPubMed
19.
go back to reference Tuncer LI, Alacam T, Oral B: Substance P expression is elevated in inflamed human periradicular tissue. J Endod. 2004, 30: 329-32. 10.1097/00004770-200405000-00006.CrossRefPubMed Tuncer LI, Alacam T, Oral B: Substance P expression is elevated in inflamed human periradicular tissue. J Endod. 2004, 30: 329-32. 10.1097/00004770-200405000-00006.CrossRefPubMed
20.
go back to reference Kraneveld AD, Nijkamp FP: Tachykinins and neuro-immune interactions in asthma. Int Immunopharmacol. 2001, 1: 1629-50. 10.1016/S1567-5769(01)00099-6.CrossRefPubMed Kraneveld AD, Nijkamp FP: Tachykinins and neuro-immune interactions in asthma. Int Immunopharmacol. 2001, 1: 1629-50. 10.1016/S1567-5769(01)00099-6.CrossRefPubMed
21.
go back to reference Felten DL, Felten SY, Bellinger DL, Lorton D: Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis. Eur J Clin Invest. 1992, 22 (Suppl 1): 37-41.PubMed Felten DL, Felten SY, Bellinger DL, Lorton D: Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis. Eur J Clin Invest. 1992, 22 (Suppl 1): 37-41.PubMed
22.
go back to reference Levite M: Nerve-driven immunity. The direct effects of neurotransmitters on T- cell function. Ann N Y Acad Sci. 2000, 917: 307-21. 10.1111/j.1749-6632.2000.tb05397.x.CrossRefPubMed Levite M: Nerve-driven immunity. The direct effects of neurotransmitters on T- cell function. Ann N Y Acad Sci. 2000, 917: 307-21. 10.1111/j.1749-6632.2000.tb05397.x.CrossRefPubMed
23.
go back to reference Bost KL, Pascual DW: Substance P: a late-acting B lymphocyte differentiation cofactor. Am J Physiol. 1992, 262: C537-45.PubMed Bost KL, Pascual DW: Substance P: a late-acting B lymphocyte differentiation cofactor. Am J Physiol. 1992, 262: C537-45.PubMed
24.
go back to reference Jain J, Loh C, Rao A: Transcriptional regulation of the IL-2 gene. Curr Opin Immunol. 1995, 7: 333-42. 10.1016/0952-7915(95)80107-3.CrossRefPubMed Jain J, Loh C, Rao A: Transcriptional regulation of the IL-2 gene. Curr Opin Immunol. 1995, 7: 333-42. 10.1016/0952-7915(95)80107-3.CrossRefPubMed
25.
go back to reference Karin M, Liu Z, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol. 1997, 9: 240-6. 10.1016/S0955-0674(97)80068-3.CrossRefPubMed Karin M, Liu Z, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol. 1997, 9: 240-6. 10.1016/S0955-0674(97)80068-3.CrossRefPubMed
26.
go back to reference Koike T, Yamagishi H, Hatanaka Y, Fukushima A, Chang JW, Xia Y, Fields M, Chandler P, Iwashima M: A novel ERK-dependent signaling process that regulates interleukin-2 expression in a late phase of T cell activation. J Biol Chem. 2003, 278: 15685-92. 10.1074/jbc.M210829200.CrossRefPubMed Koike T, Yamagishi H, Hatanaka Y, Fukushima A, Chang JW, Xia Y, Fields M, Chandler P, Iwashima M: A novel ERK-dependent signaling process that regulates interleukin-2 expression in a late phase of T cell activation. J Biol Chem. 2003, 278: 15685-92. 10.1074/jbc.M210829200.CrossRefPubMed
28.
go back to reference Gergely L, Cook L, Agnello V: A simplified method for Ca2+ flux measurement on isolated human B cells that uses flow cytometry. Clin Diagn Lab Immunol. 1997, 4: 70-4.PubMedCentralPubMed Gergely L, Cook L, Agnello V: A simplified method for Ca2+ flux measurement on isolated human B cells that uses flow cytometry. Clin Diagn Lab Immunol. 1997, 4: 70-4.PubMedCentralPubMed
29.
go back to reference Franklin RA, Tordai A, Patel H, Gardner AM, Johnson GL, Gelfand EW: Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. J Clin Invest. 1994, 93: 2134-40. 10.1172/JCI117209.PubMedCentralCrossRefPubMed Franklin RA, Tordai A, Patel H, Gardner AM, Johnson GL, Gelfand EW: Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. J Clin Invest. 1994, 93: 2134-40. 10.1172/JCI117209.PubMedCentralCrossRefPubMed
30.
go back to reference Romashkova JA, Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999, 401: 86-90. 10.1038/43474.CrossRefPubMed Romashkova JA, Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999, 401: 86-90. 10.1038/43474.CrossRefPubMed
31.
go back to reference Feske S: Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol. 2007, 7: 690-702. 10.1038/nri2152.CrossRefPubMed Feske S: Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol. 2007, 7: 690-702. 10.1038/nri2152.CrossRefPubMed
32.
go back to reference Macian F: NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005, 5: 472-84. 10.1038/nri1632.CrossRefPubMed Macian F: NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005, 5: 472-84. 10.1038/nri1632.CrossRefPubMed
33.
go back to reference Lang K, Drell TL, Niggemann B, Zanker KS, Entschladen F: Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol Lett. 2003, 90: 165-172. 10.1016/j.imlet.2003.09.004.CrossRefPubMed Lang K, Drell TL, Niggemann B, Zanker KS, Entschladen F: Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol Lett. 2003, 90: 165-172. 10.1016/j.imlet.2003.09.004.CrossRefPubMed
34.
go back to reference Bierer BE, Burakoff SJ: T cell adhesion molecules. Faseb J. 1988, 2: 2584-90.PubMed Bierer BE, Burakoff SJ: T cell adhesion molecules. Faseb J. 1988, 2: 2584-90.PubMed
35.
go back to reference Hemler ME, Jacobson JG, Brenner MB, Mann D, Strominger JL: VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation. Eur J Immunol. 1985, 15: 502-8. 10.1002/eji.1830150515.CrossRefPubMed Hemler ME, Jacobson JG, Brenner MB, Mann D, Strominger JL: VLA-1: a T cell surface antigen which defines a novel late stage of human T cell activation. Eur J Immunol. 1985, 15: 502-8. 10.1002/eji.1830150515.CrossRefPubMed
36.
go back to reference Rot A: Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today. 1992, 13: 291-4. 10.1016/0167-5699(92)90039-A.CrossRefPubMed Rot A: Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today. 1992, 13: 291-4. 10.1016/0167-5699(92)90039-A.CrossRefPubMed
37.
go back to reference Tanaka Y, Adams DH, Shaw S: Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today. 1993, 14: 111-5. 10.1016/0167-5699(93)90209-4.CrossRefPubMed Tanaka Y, Adams DH, Shaw S: Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today. 1993, 14: 111-5. 10.1016/0167-5699(93)90209-4.CrossRefPubMed
38.
go back to reference Cinamon G, Grabovsky V, Winter E, Franitza S, Feigelson S, Shamri R, Dwir O, Alon R: Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J Leukoc Biol. 2001, 69: 860-6.PubMed Cinamon G, Grabovsky V, Winter E, Franitza S, Feigelson S, Shamri R, Dwir O, Alon R: Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J Leukoc Biol. 2001, 69: 860-6.PubMed
39.
go back to reference Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature. 1993, 361: 79-82. 10.1038/361079a0.CrossRefPubMed Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature. 1993, 361: 79-82. 10.1038/361079a0.CrossRefPubMed
40.
go back to reference Takata H, Tomiyama H, Fujiwara M, Kobayashi N, Takiguchi M: Cutting edge: expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol. 2004, 173: 2231-5.CrossRefPubMed Takata H, Tomiyama H, Fujiwara M, Kobayashi N, Takiguchi M: Cutting edge: expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol. 2004, 173: 2231-5.CrossRefPubMed
41.
go back to reference Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, Imai T: Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol. 2002, 168: 6173-80.CrossRefPubMed Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, Dohmae N, Yoshie O, Imai T: Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol. 2002, 168: 6173-80.CrossRefPubMed
42.
go back to reference Chuntharapai A, Lee J, Hebert CA, Kim KJ: Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol. 1994, 153: 5682-8.PubMed Chuntharapai A, Lee J, Hebert CA, Kim KJ: Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol. 1994, 153: 5682-8.PubMed
43.
go back to reference Levite M: Towards unveiling the mystery: from stressed brain/mind to outburst of disease. Curr Opin Pharmacol. 2008, 8: 458-9. 10.1016/j.coph.2008.06.017.CrossRefPubMed Levite M: Towards unveiling the mystery: from stressed brain/mind to outburst of disease. Curr Opin Pharmacol. 2008, 8: 458-9. 10.1016/j.coph.2008.06.017.CrossRefPubMed
44.
go back to reference Bastian P, Posch B, Lang K, Niggemann B, Zaenker KS, Hatt H, Entschladen F: Phosphatidylinositol 3-kinase in the G protein-coupled receptor-induced chemokinesis and chemotaxis of MDA-MB-468 breast carcinoma cells: a comparison with leukocytes. Mol Cancer Res. 2006, 4: 411-21. 10.1158/1541-7786.MCR-06-0030.CrossRefPubMed Bastian P, Posch B, Lang K, Niggemann B, Zaenker KS, Hatt H, Entschladen F: Phosphatidylinositol 3-kinase in the G protein-coupled receptor-induced chemokinesis and chemotaxis of MDA-MB-468 breast carcinoma cells: a comparison with leukocytes. Mol Cancer Res. 2006, 4: 411-21. 10.1158/1541-7786.MCR-06-0030.CrossRefPubMed
45.
go back to reference Lang K, Drell TL, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, Entschladen F: Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer. 2004, 112: 231-8. 10.1002/ijc.20410.CrossRefPubMed Lang K, Drell TL, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, Entschladen F: Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer. 2004, 112: 231-8. 10.1002/ijc.20410.CrossRefPubMed
46.
go back to reference Bastian P, Balcarek A, Altanis C, Strell C, Niggemann B, Zaenker KS, Entschladen F: The inhibitory effect of norepinephrine on the migration of ES-2 ovarian carcinoma cells involves a Rap1-dependent pathway. Cancer Lett. 2009, 274: 218-24. 10.1016/j.canlet.2008.09.008.CrossRefPubMed Bastian P, Balcarek A, Altanis C, Strell C, Niggemann B, Zaenker KS, Entschladen F: The inhibitory effect of norepinephrine on the migration of ES-2 ovarian carcinoma cells involves a Rap1-dependent pathway. Cancer Lett. 2009, 274: 218-24. 10.1016/j.canlet.2008.09.008.CrossRefPubMed
47.
go back to reference Shimizu N, Hori T, Nakane H: An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats. Brain Behav Immun. 1994, 8: 14-23. 10.1006/brbi.1994.1002.CrossRefPubMed Shimizu N, Hori T, Nakane H: An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats. Brain Behav Immun. 1994, 8: 14-23. 10.1006/brbi.1994.1002.CrossRefPubMed
48.
go back to reference Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-5. 10.1038/227680a0.CrossRefPubMed Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-5. 10.1038/227680a0.CrossRefPubMed
49.
go back to reference Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979, 76: 4350-4. 10.1073/pnas.76.9.4350.PubMedCentralCrossRefPubMed Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979, 76: 4350-4. 10.1073/pnas.76.9.4350.PubMedCentralCrossRefPubMed
50.
go back to reference Sakkas LI, Scanzello C, Johanson N, Burkholder J, Mitra A, Salgame P, Katsetos CD, Platsoucas CD: T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol. 1998, 5: 430-7.PubMedCentralPubMed Sakkas LI, Scanzello C, Johanson N, Burkholder J, Mitra A, Salgame P, Katsetos CD, Platsoucas CD: T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol. 1998, 5: 430-7.PubMedCentralPubMed
51.
go back to reference Bastian P, Lang K, Niggemann B, Zaenker KS, Entschladen F: Myosin regulation in the migration of tumor cells and leukocytes within a three-dimensional collagen matrix. Cell Mol Life Sci. 2005, 62: 65-76. 10.1007/s00018-004-4391-6.CrossRefPubMed Bastian P, Lang K, Niggemann B, Zaenker KS, Entschladen F: Myosin regulation in the migration of tumor cells and leukocytes within a three-dimensional collagen matrix. Cell Mol Life Sci. 2005, 62: 65-76. 10.1007/s00018-004-4391-6.CrossRefPubMed
52.
go back to reference Strell C, Lang K, Niggemann B, Zaenker KS, Entschladen F: Surface molecules regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-MB-468 breast carcinoma cells and their interaction. Cell Mol Life Sci. 2007, 64: 3306-16. 10.1007/s00018-007-7402-6.CrossRefPubMed Strell C, Lang K, Niggemann B, Zaenker KS, Entschladen F: Surface molecules regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-MB-468 breast carcinoma cells and their interaction. Cell Mol Life Sci. 2007, 64: 3306-16. 10.1007/s00018-007-7402-6.CrossRefPubMed
53.
go back to reference Shen DT, Ma JS, Mather J, Vukmanovic S, Radoja S: Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells. J Leukoc Biol. 2006, 80: 827-37. 10.1189/jlb.0603298.CrossRefPubMed Shen DT, Ma JS, Mather J, Vukmanovic S, Radoja S: Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells. J Leukoc Biol. 2006, 80: 827-37. 10.1189/jlb.0603298.CrossRefPubMed
Metadata
Title
Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes
Authors
Carina Strell
Anne Sievers
Philipp Bastian
Kerstin Lang
Bernd Niggemann
Kurt S Zänker
Frank Entschladen
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2009
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-10-62

Other articles of this Issue 1/2009

BMC Immunology 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.